60 Degrees Pharmaceuticals Inc.

SXTP | NASDAQ

Price Alert Chart Builder DCF Calculator

$1.01

$0 (0.00%)

Sep 22, 2026, 12:47 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

+0.00%

(1D)

Rating

Updated: Aug 19, 2026

Fundamentals Weak

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $814.7K

1D Range

0.96 1.07

52W Range

0.84 8.62

Valuation (TTM)

PE -0.17

PB 0.32

EV/EBITDA 0.03

Valuation (NTM)

Forward PE N/A

Forward PEG -0.01

Price Target $13.85

Cash Flow

FCF Yield -484.5%

SBC Adj. FCF Yield -498.3%

SBC Impact -2.8%

Margins

Gross Margin 19.4%

Operating Margin -774.9%

FCF Margin -355.3%

Growth (CAGR)

Revenue 3Y | 5Y 87.2% | -14.3%

Dil EPS 3Y | 5Y 5.0% | -45.1%

FCF 3Y | 5Y 21.5% | -45.4%

Returns

ROA -189.4%

ROE -211.6%

ROIC -321.2%

Financial Health

Net Cash

$1.02M

Current Ratio 2.32

Interest Coverage -1,134.85

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

60 Degrees Pharmaceuticals, Inc. is a specialty pharmaceutical firm dedicated to developing and bringing to market therapies aimed at preventing and treating infectious diseases within the United Stat...

Sector Healthcare

Industry Biotechnology

Employees 3

IPO Date Jul 11, 2023

Website www.60degreespharma.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.

Earnings

Next Earnings

Nov 12, 2026

EPS Est

Pro

Rev Est

Pro

Earnings Details ➞

Analyst Summary

# of Analysts

Consensus

Hold

Price Target

$13.85

Upside

+1271.29%

Buy (1)

Hold (1)

Sell (0)

Analyst Details ➞